Documents

Files(46)

Page 1 of 2 Next page Total results: 46
Name Size/Type Description Date
ABVD consent 112KB PDF ABVD consent 21 Apr 2020
Acalabrutinib consent 113KB PDF Acalabrutinib consent 05 Jun 2020
BEACOPP-14 consent 112KB PDF BEACOPP-14 consent 21 Apr 2020
Brentuximab vedotin consent 110KB PDF Brentuximab consent 31 Aug 2020
Brentuximab Vedotin-CHP consent 112KB PDF Brentuximab vedotin - CHP consent 31 Aug 2020
ChlVPP consent 111KB PDF ChlVPP consent 21 Apr 2020
Escalated BEACOPDac Consent 113KB PDF Escalated BEACOPDac Consent 11 Mar 2022
ESHAP consent 111KB PDF ESHAP consent 21 Apr 2020
GDP consent 110KB PDF GDP consent 21 Apr 2020
Glofitamab consent 114KB PDF Glofitamab consent 17 Nov 2023
Glofitamab Patient Alert Card 102KB PDF Glofitamab Patient Alert Card 17 Nov 2023
High dose Methylprednisolone consent 108KB PDF High dose Methylprednisolone consent 21 Apr 2020
High dose MTX and Cytarabine (Ferreri) consent 111KB PDF High dose MTX and Cytarabine (Ferreri) consent 21 Apr 2020
High dose MTX for CNS prophylaxis consent 109KB PDF High dose MTX for CNS prophylaxis consent 21 Apr 2020
Ibrutinib + Venetoclax consent 115KB PDF Ibrutinib + Venetoclax consent 21 Dec 2023
Ibrutinib consent 111KB PDF Ibrutinib consent 03 Jun 2020
IVE consent 110KB PDF IVE consent 21 Apr 2020
MATRix consent 116KB PDF MATRix consent 04 Oct 2024
mini-BEAM consent 111KB PDF mini-BEAM consent 21 Apr 2020
Nivolumab consent 112KB PDF Nivolumab consent 05 Jun 2020
Nordic consent 113KB PDF Nordic consent 21 Apr 2020
O-CHOP consent 113KB PDF O-CHOP Consent 06 Sep 2021
O-CVP consent 113KB PDF O-CVP consent 06 Sep 2021
O-Venetoclax consent 114KB PDF O - Venetoclax consent 03 Dec 2020
Obinutuzumab-Bendamustine consent 117KB PDF Obinutuzumab-Bendamustine consent 28 May 2021
Obinutuzumab-Chlorambucil consent 113KB PDF O-Chlorambucil consent 03 Dec 2020
Pembrolizumab consent 113KB PDF Pembrolizumab consent 05 Jun 2020
Pixantrone consent 109KB PDF Pixantrone consent 21 Apr 2020
Polatuzumab - R - CHP consent 116KB PDF Polatuzumab - R - CHP consent 04 Oct 2024
Polatuzumab vedotin R-Bendamustine consent 116KB PDF Polatuzumab vedotin R-Bendamustine Consent 28 May 2021

Chemotherapy Consent Forms for Haematology

All consent forms on this website are for the use of St Luke’s Cancer Alliance staff in respect of St Luke’s Cancer Alliance patients only.
For those who do not work within St Luke’s Cancer Alliance:
Use of this site and any information on it is at your own risk. We do not accept responsibility for the use of any information that may be set out on the website. You assume full responsibility for the use of the information.  You may wish to take your own legal advice before using any of the consent forms.

Please note that the consent forms below are not tumour-specific; one consent form may be used to consent patients for more than one St Luke’s Alliance chemotherapy protocol which uses the same combination of chemotherapy.

These consent forms should act as an aide-memoire to health professionals and patients, by providing a check-list of the kind of information which patients should be offered, and by enabling the patient to have a written record of the main points discussed.

The relevant Macmillan/CRUK leaflet(s) should also be provided to each patient before consent. In no way, however, should written information given to the patient be regarded as a substitute for face-to-face discussions with the patient.